Guanhua Yu
Beijing, 100730, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Effectiveness and conversion outcomes of immune checkpoint inhibitors combined with lenvatinib and GEMOX chemotherapy as first-line treatment for advanced gallbladder cancer: A multicenter study.
Journal: Chinese medical journal
Published: December 02, 2025
CCL20-CCR6 axis in autoimmune disease and cancer progression: clinical and therapeutic implications.
CCL20-CCR6 axis in autoimmune disease and cancer progression: clinical and therapeutic implications.
Journal: Cell communication and signaling : CCS
Published: November 01, 2025
Development and validation of machine learning models for predicting synchronous lung metastasis in United States colorectal cancer patients: a SEER database analysis.
Journal: Translational cancer research
Published: October 11, 2025
KRASG12V/A146T mutations are associated with nCRT resistance via enhanced DNA double-strand break repair and support a deep learning prediction framework in LARC.
Journal: Cellular & molecular biology letters
Published: September 26, 2025
Local-regional therapy plus ICIs, chemotherapy, and lenvatinib versus ICIs plus chemotherapy in advanced intrahepatic cholangiocarcinoma: a multicenter study.
Journal: Cancer immunology, immunotherapy : CII
Published: August 28, 2025
Immunotherapy change overcomes acquired resistance after chemo-immunotherapy in unresectable biliary tract cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: August 07, 2025
Lenvatinib enhances the response of biliary tract cancer to anti-HER2 therapy.
Journal: Signal transduction and targeted therapy
Published: July 31, 2025
Local-regional therapy combined with immune checkpoint inhibitors and lenvatinib versus immune checkpoint inhibitors plus chemotherapy in advanced intrahepatic cholangiocarcinoma: a multicenter cohort study.
Journal: Cancer immunology, immunotherapy : CII
Published: May 27, 2025
Global research landscape and trends of immunotherapy in biliary tract cancers.
Journal: Chinese medical journal
Published: May 08, 2025
Efficacy and safety of local-regional therapy combined with chemotherapy, immune checkpoint inhibitors and lenvatinib as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study.
Journal: Cancer immunology, immunotherapy : CII
Published: March 03, 2025
Effectiveness and safety of PD-1/PD-L1 inhibitors plus lenvatinib with or without Gemox chemotherapy in advanced intrahepatic cholangiocarcinoma.
Journal: BMC cancer
Published: December 26, 2024
Development of prediction models for liver metastasis in colorectal cancer based on machine learning: a population-level study.
Journal: Translational cancer research
Published: July 13, 2024
Last Updated: 09/26/2026